Balance Labs annual ebitda
2017
2018
2021
Balance Labs's calculated EBITDA was $224,506 for fiscal 2021.
View full Balance Labs company overview| Fiscal year | Period ended | EBITDA | Change | Growth |
|---|---|---|---|---|
| 2021 | 2021-12-31 | $224,506 | $824,025 | — |
| 2018 | 2018-12-31 | −$599,519 | −$69,841 | — |
| 2017 | 2017-12-31 | −$529,678 | — | — |
| Fiscal quarter | Period ended | EBITDA | Change | YoY change |
|---|---|---|---|---|
| Q3 2021 | 2021-09-30 | $100,184 | $212,069 | — |
| Q2 2021 | 2021-06-30 | −$95,593 | $106,879 | — |
| Q3 2020 | 2020-09-30 | −$86,367 | $71,118 | — |
| Q2 2020 | 2020-06-30 | −$95,908 | $45,272 | — |
| Q2 2019 | 2019-06-30 | −$111,885 | — | — |
| Q1 2019 | 2019-03-31 | −$202,472 | — | — |
| Q3 2018 | 2018-09-30 | −$157,485 | — | — |
| Q1 2017 | 2017-03-31 | −$141,180 | — | — |
Across the available reported history, Balance Labs's ebitda increased from −$599,519 to $224,506, a change of $824,025. The latest reported quarter, Q3 2021, shows $100,184.
EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.
TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Balance Labs filings at SEC.gov ↗